abstract |
The invention relates to the chemoprevention of prostate cancer and, more particularly, provides a chemopreventive agent, e.g. toremifene citrate, for use in treating prostate intraepithelial neoplasia (PIN), especially high grade prostate intraepithelial neoplasia (HGPIN). |